1. Reenders K, de Nobel E, van den Hoogen HJ, et al. Diabetes and its long term complications in general practice: a survey in a well-defined population. Fam Pract. 1993;10:169-172
2. Gerstein HC, Mann JF,Yi Q, et al.Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426.
3. Damasceno, A. Azevedo, C. Silva-Matos, et al. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition,” Hypertension, vol. 54, no. 1, pp. 77–83, 2009.
4. Z. H. Israili, R. Hern´andez-Hern´andez, and M. Valasco, “The future of antihypertensive treatment,” American Journal of Therapeutics, vol. 14, no. 2, pp. 121–134, 2007.
5. Horl MP, Horl WH.Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39:227-44.
6. Tycho Vuurmans JL, Boer WH, Bos WJ, et al. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177-83.
7. Sobotova D, Zharfbin A, Svojanovsky J, et al.Hypertension in hemodialyzed uremic patients. Vnitr Lek. 1999;45:641-4.
8. Raine AEG, Bedford L, Simpson AWM, , et al Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure Kidney Intern 1993; 43: 700–705
9. Lim S, Kim MJ, Choi SH, et al. Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr 2013; 97: 524–530.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81.
11. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39–48.
12. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol. 2001;12:1079–1084.
13. Zoccali C, Mallamaci F, Tripepi G, et al. Norepinephrine and concentric hypertro-phy in patients with end-stage renal disease. Hypertension 2002;40:41 46.
14. Dominiczak AF, Lyall F, Morton JJ et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperpar-athyroidism. Clin Sci 1990;78:127–32
15. Almqvist EG, Bondeson AG, Bondeson L et al. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardio-graphy before and after parathyroidec-tomy. Surgery 2002;132:1126–32.
16. Anderson GH.,Effect of age on hypertension: analysis of over 4,800 referred hypertensive patients. Saudi J Kidney Dis Transpl. 1999 Jul Sep;10(3):286-97.
17. Pietschmann P, Schernthaner G, Woloszczuk W .Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia .1988;31: 892–895
18. Isaia GC, Ardissone P, Di Stefano M, et al. .Bone metabolism in type 2 diabetes mellitus. Acta Diabetol.1999;36: 35–38 .
19. Pittas AG, Sun Q, Manson JE, Dawson- Hughes B, et al. Plasma 25 hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care.2010; 33:2021–2023
20. GagnonC, Lu ZX,Magliano DJ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care 2011;34:1133–1138.
21. Suzuki et al Hypovitaminosis D in Type 2 Diabetes Mellitus:Association with Microvascular complications and type of treatement Endocrine Journal 2006, 53 (4), 503–510
22. Rolf Jordea, Johan Svartbergb and Johan Sundsfjordc. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men. Journal of Hypertension 2005, Vol 23 No 9.
23. Helmut Schiffl and Susanne M. Lang . Hypertension secondary to PHPT cause or coincidence International Journal of Endocrinology Volume 2011, Article ID 974647, 6 pages.
24. Omid Sedighi,1 Aieh Makhlough,Zahra Kashi, et al. Relationship between serum parathyroid hormone and hypertension in hemodialysis patients Iranian Journal of Kidney Diseases. July 2011; Vol 5 :No 4.
25. Jared P. Reis,Deborah L. Wingard, Elizabeth Barrett Connor. Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults. DIABETES CARE, VOLUME 30, NUMBER 6, JUNE 2007;1549-1555
26. Andrew St John, Ian Dick, Kirsten Hoad, et al. Relationship between calcitrophic hormones and blood pressure in elderly subjects. Eur J Endocrinol May 1, 1994 130 446-450
27. M. B. Snijder, P. Lips, J. C. Seidell et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. Journal of Internal Medicine 2007 261; 558–565.
28. R Chan, D Chan, J Woo et al. Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. Journal of Human Hypertension (2012) 26, 20–27.
29. Michael Pfeifer, Bettina Begerow, Helmut W. Minne, et al. Effects of a Short-Term Vitamin D3 and Calcium Supplementation on Blood Pressure and Parathyroid Hormone Levels in Elderly Women The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 4.
30. Alexandra Jungert1, Heinz J Roth2 and Monika Neuhäuser-Berthold. Serum 25-hydroxyvitamin D3, parathyroid hormone and blood pressure in an elderly cohort from Germany: a cross-sectional study. Nutrition & Metabolism 2012, 9:20.
31. Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt sensitive animals. Proc Natl Acad Sci USA. 2007;104:16810–16815
32. Osman Kuloğlu, Mustafa Gür, Taner Şeker, et al. Serum 25-hydroxyvitamin D level is associated with aortic distensibility and left ventricle hypertrophy in newly diagnosed type 2 diabetes mellitus. Diabetes & Vascular Disease Research2013; 0(0) 1–4.
33. F. N. Saleh, H. Schirmer, J. Sundsfjord, R. Jorde. Parathyroid hormone and left ventricular Hypertrophy. European Heart Journal (2003) 24, 2054–2060
34. Al-Hilali N, Hussain N, Ataia AI, et al. Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis. Indian J Nephrol. 2009 Oct;19(4):1537.
35. AZAK, E. ABAYLI, M. D. AYLI et al. Cardiac complications of secondary hyperparathyroidism in chronic hemodialysis patients Turk J Med Sci2011; 41 (5): 789-794.